Literature DB >> 3574353

Cytotoxicity of ester and ether lysophospholipids on Leishmania donovani promastigotes.

V Achterberg, G Gercken.   

Abstract

The cytotoxic activity of four ester lysophospholipids, three ether lysophospholipids, and two radylglycerols on Leishmania donovani promastigotes was determined by measuring the inhibition of cell growth. The 1-acyl lysophospholipids reduced cell growth to 50% of controls at concentrations of 6.4-10.9 microM. In contrast, 1-O-alkenyl-sn-glycero-3-phosphoethanolamine, 1-O-hexadecyl-sn-glycero-3-phosphocholine, and 1-O-hexadecyl-sn-glycerol already showed a 50% inhibition of growth at concentrations between 2.1 and 2.8 microM. Moreover, the unnatural alkyl lysophospholipid analogue 1-O-octadecyl-2-methoxy-sn-glycero-3-phosphocholine was even 10-fold more toxic. Incubations of L. donovani promastigotes with radioactively labelled ether lysophospholipids revealed a rapid uptake of these compounds and their incorporation into cellular lipids at a non-toxic concentration of 1.0 microM. An accumulation of the lysophospholipids in the cell due to insufficient metabolism may be the cause of its cytotoxic effect. The sensitivity of L. donovani cells towards ether lysophospholipids was found to be similar to that reported for tumor cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3574353     DOI: 10.1016/0166-6851(87)90146-0

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  4 in total

1.  Miltefosine (Impavido): the first oral treatment against leishmaniasis.

Authors:  H Sindermann; S L Croft; K R Engel; W Bommer; H J Eibl; C Unger; J Engel
Journal:  Med Microbiol Immunol       Date:  2003-09-26       Impact factor: 3.402

2.  Plasticity in chromosome number and testing of essential genes in Leishmania by targeting.

Authors:  A K Cruz; R Titus; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

3.  Clinical efficacy and tolerance of miltefosine in the treatment of canine leishmaniosis.

Authors:  Virginie Woerly; Laurence Maynard; Annaële Sanquer; Hyone-Myong Eun
Journal:  Parasitol Res       Date:  2009-03-26       Impact factor: 2.289

4.  Antileishmanial structure-activity relationships of synthetic phospholipids: in vitro and in vivo activities of selected derivatives.

Authors:  Karin Seifert; Andreas Lemke; Simon L Croft; Oliver Kayser
Journal:  Antimicrob Agents Chemother       Date:  2007-10-01       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.